Zuo -Supplementary Figure 1 (page 1 of 2)

Zuo-Supplementary Figure 1 (page 1 of 2)

neg1 neg2 neg3 Founder0.0

l Villin-15-LOX-1-A Mouse Line Founder

neg1 neg2 neg3 Founder0.0

Villin-15-LOX-1-B Mouse Line Founder

Wild type Villin-15-LOX-1 (+/-) Villin-15-LOX-1 (+/+)0.0

Villin-15-LOX-1-A Mouse Line

Wild type Villin-15-LOX-1 (+/-) Villin-15-LOX-1 (+/+)0.0

Villin-15-LOX-1-B Mouse Line

Small intestine Large intestine0

Villin-15-LOX-1(+/-)

Villin-15-LOX-1(+/+)

Wild type

Small Intestine Large intestine0

3 Villin-15-LOX-1-B Mouse Line

Wild type

Villin-15-LOX-1(+/-)

Villin-15-LOX-1(+/+)

Heart Liver Kidney Spleen Small Large0.0

Intestine

Heart Liver Kidney Spleen Small Large0.0

Villin-15-LOX-1-B Mouse Line

Intestine

Large intestine Small intestine Liver

15-LOX-1

Wild typeVillin-15-LOX-1 +/-Villin-15-LOX-1 +/+

15-LOX-1

Wild typeVillin-15-LOX-1 +/-Villin-15-LOX-1 +/+

Large intestine Small intestine Liver

+-- -+

Villin 15-LOX-1-A Mouse Line

Villin 15-LOX-1-B Mouse Line

Supplementary Figure 1. Generation of villin-15-LOX-1 mice. (A and B) Villin-15-LOX-1 mouse genotyping. Quantitative real time polymerase chain reaction (qPCR) analysis of genomic human 15-LOX-1 (h15-LOX-1) in littermates generated by pronuclear injections of the villin-15-LOX-1 construct into fertilized C57BL/6 (villin-15-LOX-1-A) and FVB/N (villin-15-LOX-1-B) mouse oocytes. The levels of genomic h15-LOX-1 were calculated relative to the level of a calibrator sample (founder). Values are means and 95% confidence intervals (CIs) for four (A) or three (B) replicate measurements. *P < .001, two-sided ANOVA for founders vs negative mice. C and D) Identification of heterozygotes and homozygotes among villin-15-LOX-1 mouse lines. Founders for villin-15-LOX-1-A and villin-15-LOX-1-B mouse lines were bred with wild type (WT) mice from the same genetic background. Genomic qPCR analysis of h15-LOX-1 was performed in littermates for each cell line. The levels of genomic h15-LOX-1 were calculated relative to the level of a calibrator sample (heterozygotes: villin-15-LOX-1(+/-)). Values are means with 95% CIs for four replicate measurements. *P < .001 (two-sided ANOVA) for all comparisons (WT vs villin-15-LOX-1 (+/-), WT vs villin-15-LOX-1(+/+), villin-15-LOX-1(+/-) vs villin-15-LOX-1(+/+)). E-J) Targeted intestinal 15-LOX-1 expression in villin-15-LOX-1 mice. E and F) qRT-PCR analysis of15-LOX-1 mRNA expression in small and large intestinal crypts of villin-15-LOX-1-A and villin-15-LOX-1-B heterozygotes and homozygotes and WT mice. Values are means with 95% CIs for triplicate experiments. *P < .001 (two-sided ANOVA) for all comparisons (WT vs villin-15-LOX-1(+/-), WT vs villin-15-LOX-1(+/+), villin-15-LOX-1(+/-) vs villin-15-LOX-1(+/+)). G and H) qRT-PCR analysis of 15-LOX-1 mRNA expression in isolated intestinal crypts from small and large intestine and various organs from a villin-15-LOX-1-A and villin-15-LOX-1-B mice. Values are means with 95% CIs for triplicate experiments. *P < .001 (two-sided ANOVA) for intestine (large or small) vs other organs. I and J) 15-LOX-1 protein expression from intestinal crypts and liver of villin-15-LOX-1-A (I) and villin-15-LOX-1-B (J) mice. Positive control was HCT-116 cells transfected with a 15-LOX-1 expression vector.

Continue-Zuo-Supplementary Figure 1I

Zuo -Supplementary Figure 1 (page 1 of 2)

Documents

Transcript of Zuo -Supplementary Figure 1 (page 1 of 2)

images.nature.com · Web viewSupplementary Figure 7 Supplementary Figure 3 Supplementary Figure 1 Supplementary Materials Supplementary Figures S1-S7 Supplementary Tables S1-S7 Clinical

Supplementary figure S1.

Supplementary Figure 1

Supplementary Figure 1

Supplementary Figure 2

Supplementary Figure Legends

Supplementary Figure S1

Supplementary information for: Discovery and … · Supplementary Figure S2 Supplementary Figure S3 Supplementary Figure S4 Supplementary Figure S5 Supplementary Figure S6 Supplementary

Supplementary Figure 5

Supplementary figure 2.

Supplementary Figure 1A HNF4AWNT5AVANGL1PCLB1 Supplementary Figure 1B Supplementary Figure 1. (A) HNF4A TFBSs of the three genes: VANGL1, WNT5A and PLCB1.

Supplementary Figure 1. Supplementary Figure 2 Supplementary Figure 3 A B.

Supplementary Figure 1.

Supplementary Figures: Supplementary Figure 1 – PANCAN ...df6sxcketz7bb.cloudfront.net/manuscripts/88000/88755/jci.insight.88755.sd.pdfSupplementary Figures: Supplementary Figure

SUPPLEMENTARY MATERIAL: SUPPLEMENTARY FIGURE 2cambridge.org:id:article:S... · SUPPLEMENTARY MATERIAL: SUPPLEMENTARY FIGURE 2 Image gallery to accompany John Robb (2015), “Prehistoric

Supplementary Figure 1

Supplementary Materials Supplementary Figure Legends ...

Supplementary Figure 5.

Supplementary figure S1

media.nature.com · 1 Supplementary Materials Supplementary Table S1 Supplementary Table S2 Supplementary Table S3 Supplementary Figure S1 Supplementary Figure S2 Supplementary Figure